2022 annual financial data
Traws Pharma 2022 Revenue growth
Direct answer
Revenue growth was 0%.
Operating income was -19,627,000 USD and net income was -18,964,000 USD.
Operating cash flow was -16,294,000 USD.
Get free Traws Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 226,000 USD
- Operating income
- -19,627,000 USD
- Net income
- -18,964,000 USD
- Operating cash flow
- -16,294,000 USD